Research Study: NASA
Condition:
coronary artery disease
Study Sponsor: Minneapolis Heart Institute Foundation
Study Investigator: Emmanouil Brilakis, MD
Study Contact: Bavana Rangan
bavana.rangan@allina.com
612-863-3852
Every research study comes with its own unique risks and benefits; the study team will assess whether you’re an eligible candidate and ensure you’re provided with all the information you need to decide if participating is right for you.
About this Study:

The primary study objective of the NASA registry is to evaluate the 12-month incidence of target vessel failure (TVF) in patients who present with saphenous vein graft (SVG) lesions and undergo percutaneous coronary intervention (PCI) of the corresponding native coronary artery.
Eligibility Criteria:

Inclusion Criteria:

  1. Age 18 years or older
  2. Presentation with a 50-99% de novo SVG lesion SVG lesion that is considered to cause clinical symptoms and is treated with percutaneous coronary intervention of the corresponding native coronary artery using a SYNERGY stent
  3. Has provided informed consent and agrees to participate

Interested in participating in this study?

Reach out to the study contact directly, or fill out this form and we will contact you and assess whether you are an eligible candidate!